original ) (raw )Role of Helicobacter pylori Infection in Gastroduodenal Damage in Patients Starting NSAID Therapy: 4 Months Follow-Up Study
Tamara Alempijevic
Digestive Diseases and Sciences, 2010
View PDFchevron_right
Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy
Pierre-Yves Donnio
Gut, 1992
View PDFchevron_right
Helicobacter pylori infection and the use of NSAIDs
Luca Luca
2000
View PDFchevron_right
Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care
Elisa Morini
Internal and Emergency Medicine
View PDFchevron_right
Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: The role of Helicobacter pylori
David Loeb
Gastroenterology, 1992
View PDFchevron_right
Specifics of Helicobacter pylori Infection/NSAID Effects in the Elderly
Mladen Davidovic
View PDFchevron_right
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate
Rupert Leong
The American Journal of Medicine, 2001
View PDFchevron_right
Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study
Yoshiro Kawahara
Gut and liver, 2015
View PDFchevron_right
Gastropathy of old age: Helicobacter pylori infection or NSAID use
Dragoslav Milosevic , Mladen Davidovic
MedGenMed : Medscape general medicine, 2004
View PDFchevron_right
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial
Harald Vonkeman
Helicobacter, 2007
View PDFchevron_right
Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis
Ernst J Kuipers
Journal of Clinical Gastroenterology, 2009
View PDFchevron_right
The Association of Helicobacter Pylori Infection and Non-Steroidal Anti-Inflammatory Drugs in Peptic-Ulcer Disease
Sergio Zepeda-gomez
American Journal of Gastroenterology
View PDFchevron_right
Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs
sushna maharjan
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
What effect does Helicobacter pylori infection have on the risk of peptic ulceration in patients receiving NSAIDs for rheumatoid arthritis?
Clive Kelly
European Journal of Internal Medicine, 2002
View PDFchevron_right
Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration
Imad Non
Journal of Clinical Pathology, 1992
View PDFchevron_right
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users
Pilar Roncales
The American Journal of Gastroenterology, 2015
View PDFchevron_right
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users
Xavier Calvet
Alimentary Pharmacology and Therapeutics, 2005
View PDFchevron_right
The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group
Richard Feltbower
2000
View PDFchevron_right
The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010
Munir Pirmohamed
Alimentary Pharmacology & Therapeutics, 2012
View PDFchevron_right
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial
Wilfred Weinstein
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users
Xavier Calvet
Alimentary Pharmacology and Therapeutics, 2000
View PDFchevron_right
On dissonances, Helicobacter pylori and NSAIDs
Xavier Calvet
Alimentary Pharmacology and Therapeutics, 2000
View PDFchevron_right
Assessment of Helicobacter pylori eradication in patients on NSAID treatment
Matthijs Janssen
BMC Gastroenterology, 2012
View PDFchevron_right
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects
Marilisa Franceschi
Alimentary Pharmacology & Therapeutics, 2000
View PDFchevron_right
Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis
Bengt Sandstedt
Digestive Diseases and Sciences, 1993
View PDFchevron_right
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users
Neville Yeomans
Gut, 2002
View PDFchevron_right
Non-Steroidal Anti-Inflammatory Drugs: Identifying the Risk Factors in the Patients
Ghulam Mashori
Journal of the Liaquat University of Medical and Health Sciences, 2009
View PDFchevron_right
Comparative study between H. Pylori induced and NSAIDs induced peptic ulcer
Krishnendhu Ajayakumar
Journal of Current Medical Research and Opinion, 2021
View PDFchevron_right
Gastritis from NSAIDS to Helicobacter pylori
Stephen Rubesin
Abdominal Imaging, 2005
View PDFchevron_right
Helicobacter pylori infection and peptic ulcer disease
Marion Rowland
Current Opinion in Gastroenterology, 1993
View PDFchevron_right
Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drug Use in Bleeding Peptic Ulcers
Zainab Irshad
Pakistan Journal of Health Sciences
View PDFchevron_right